Drugmaker Execs Hid Approval Process Roadblocks, Suit Says
By Gina Kim · March 26, 2025, 7:25 PM EDT
A Sage Therapeutics Inc. investor sued the company's executives in New York federal court Wednesday alleging they hid significant setbacks affecting the regulatory approval for its drug candidates intended to treat mood...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login